Free Trial

Revolution Medicines (RVMD) SEC Filings & 10K Form

Revolution Medicines logo
$37.00 -0.19 (-0.51%)
Closing price 03:57 PM Eastern
Extended Trading
$37.39 +0.39 (+1.05%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Revolution Medicines SEC Filings

DateFilerForm TypeView
06/24/2025
6:05 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
3:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
3:23 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
3:23 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
4:05 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2025
4:25 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Wei Lin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
8:22 AM
Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G
05/15/2025
8:23 AM
Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G/A
05/15/2025
8:24 AM
Farallon Capital Partners, L.P. (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G/A
05/14/2025
11:29 AM
JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G/A
04/28/2025
5:27 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4/A
03/24/2025
3:55 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:32 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
4:40 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:40 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:41 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:42 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:43 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:42 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
4:14 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:47 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:18 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:02 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:03 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:00 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:01 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wang Xiaolin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:01 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Wei Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:02 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:02 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:44 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
10:25 AM
JANUS HENDERSON GROUP PLC (Filed by)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form SCHEDULE 13G
01/22/2025
4:30 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
3:50 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:08 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:09 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:06 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Is Elon's empire crumbling? (Ad)

The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Click here to see the Tesla shock that could blindside everyone.
12/16/2024
8:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:42 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
7:01 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:39 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:57 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/05/2024
3:18 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
8:37 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form FWP
12/02/2024
4:21 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
12/02/2024
6:30 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:20 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
9:52 AM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/06/2024
4:07 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:05 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:10 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:42 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:43 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:30 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
5:43 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
5:05 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:07 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:29 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:30 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
4:31 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:03 AM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
3:16 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:23 PM
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Weber Barbara (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:33 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:16 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:17 PM
Horn Margaret A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:18 PM
Anders Jack (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:06 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:41 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
5:22 PM
Horn Margaret A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:37 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:15 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/16/2024
4:24 PM
Anders Jack (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:23 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
3:15 PM
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:48 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2024
4:34 PM
Clyburn Frank (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:07 PM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 424B5
08/02/2024
4:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:29 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
4:05 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
07/15/2024
3:27 PM
Kelsey Stephen Michael (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
7:03 AM
Revolution Medicines (Filer)
Revolution Medicines, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:35 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
3:36 PM
GOLDSMITH MARK A (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:36 PM
Patel Sushil (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:36 PM
Cislini Jeff (Reporting)
Revolution Medicines (Issuer)
Revolution Medicines, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
3:19 PM
Cislini Jeff (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:19 PM
Patel Sushil (Reporting)
Revolution Medicines (Subject)
Revolution Medicines, Inc. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RVMD) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners